Certified by Founder Lodge
Longitude Capital
United States - Menlo Park, CA
INVESTOR
1 Disclosed Funding Rounds $75,000,000
10 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Longitude Capital specializes in making venture growth investments in biotechnology, medical technology and health solutions companies that seek to improve clinical outcomes, enhance quality
| Company | Date | Round | Raised |
|---|---|---|---|
 Cortica |
April, 19 ,2023 | Unknown | $75,000,000 |
 Quanta Therapeutics |
May, 23 ,2023 | Series D | $50,000,000 |
 OrsoBio |
November, 08 ,2023 | Series A | $60,000,000 |
 Lassen Therapeutics |
December, 21 ,2023 | Series B | $85,000,000 |
 Nalu Medical, Inc. |
January, 05 ,2024 | Unknown | $65,000,000 |
 Cohere Health |
February, 06 ,2024 | Unknown | $50,000,000 |
 Endogenex |
June, 26 ,2024 | Series C | $88,000,000 |
 Alpha-9 Oncology |
October, 24 ,2024 | Series C | $175,000,000 |
 Veradermics |
December, 12 ,2024 | Series B | $75,000,000 |
 Aviceda Therapeutics |
January, 08 ,2025 | Series C | $207,500,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
